These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7901035)

  • 1. Antinociceptive effect of systemic PC 12, a prodrug mixed inhibitor of enkephalin-degrading enzymes, in normal and arthritic rats.
    Perrot S; Kayser V; Fournié-Zaluski MC; Roques BP; Guilbaud G
    Eur J Pharmacol; 1993 Sep; 241(1):129-33. PubMed ID: 7901035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats.
    Kayser V; Fournie-Zaluski MC; Guilbaud G; Roques BP
    Brain Res; 1989 Sep; 497(1):94-101. PubMed ID: 2790459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation.
    Noble F; Fournié-Zaluski MC; Roques BP
    Neuropharmacology; 1994 Jan; 33(1):135-40. PubMed ID: 7910383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.
    Maldonado R; Valverde O; Turcaud S; Fournié-Zaluski MC; Roques BP
    Pain; 1994 Jul; 58(1):77-83. PubMed ID: 7970841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.
    Le Guen S; Mas Nieto M; Canestrelli C; Chen H; Fournié-Zaluski MC; Cupo A; Maldonado R; Roques BP; Noble F
    Pain; 2003 Jul; 104(1-2):139-48. PubMed ID: 12855323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management.
    Nieto MM; Wilson J; Walker J; Benavides J; Fournié-Zaluski MC; Roques BP; Noble F
    Neuropharmacology; 2001 Sep; 41(4):496-506. PubMed ID: 11543770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
    Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
    Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes.
    Fournié-Zaluski MC; Coric P; Turcaud S; Lucas E; Noble F; Maldonado R; Roques BP
    J Med Chem; 1992 Jun; 35(13):2473-81. PubMed ID: 1352352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine.
    Desmeules JA; Kayser V; Gacel G; Guilbaud G; Roques BP
    Brain Res; 1993 May; 611(2):243-8. PubMed ID: 8392893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
    Cook CD; Nickerson MD
    J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of specific delta and kappa opioid receptor antagonists on the bidirectional dose-dependent effect of systemic naloxone in arthritic rats, an experimental model of persistent pain.
    Cattaneo I; Kayser V; Guilbaud G
    Brain Res; 1993 Oct; 623(2):201-7. PubMed ID: 8221101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antinociceptive effects of clonidine systemically administered in an experimental model of clinical pain, the arthritic rat.
    Kayser V; Guilbaud G; Besson JM
    Brain Res; 1992 Oct; 593(1):7-13. PubMed ID: 1360867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
    Cox ML; Welch SP
    Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effect and interaction of uncompetitive and competitive NMDA receptor antagonists upon capsaicin and paw pressure testing in normal and monoarthritic rats.
    Pelissier T; Infante C; Constandil L; Espinosa J; Lapeyra CD; Hernández A
    Pain; 2008 Jan; 134(1-2):113-27. PubMed ID: 17517475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive and anti-arthritic properties of hydroethanolic leaf extract of Clausena anisata (Willd.) Hook. f. ex Benth (Rutaceae) in Rodents: possible mechanism of actions.
    Ishola IO; Olayemi SO; Oreagba IA; Ifeanyi CI; Popoola TO
    Niger J Physiol Sci; 2015 Dec; 30(1-2):39-49. PubMed ID: 27506169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effect of systemic kelatorphan, in mononeuropathic rats, involves different opioid receptor types.
    Lee SH; Kayser V; Guilbaud G
    Eur J Pharmacol; 1994 Oct; 264(1):61-7. PubMed ID: 7828644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats.
    Kita A; Imano K; Seto Y; Yakuo I; Deguchi T; Nakamura H
    Jpn J Pharmacol; 1997 Dec; 75(4):337-46. PubMed ID: 9469639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice.
    Honda M; Okutsu H; Matsuura T; Miyagi T; Yamamoto Y; Hazato T; Ono H
    Jpn J Pharmacol; 2001 Dec; 87(4):261-7. PubMed ID: 11829145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs.
    Chen H; Noble F; Roques BP; Fournié-Zaluski MC
    J Med Chem; 2001 Oct; 44(21):3523-30. PubMed ID: 11585456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.